Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram orally dispersible tablet bioequivalence crossover study in healthy men
NL-OMON32494Active, not recruiting
- Sponsor
- Lundbeck
- Start
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of escitalopram in major depressive disorder (MDD) and anxiety disorder (2 arms), sponsored by Lundbeck. Primary endpoints: AUC and Cmax. Started Dec 2009; status: active, not recruiting.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)anxiety disorder
Beyond the preview
Go deeper on NL-OMON32494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON32494.